|
시장보고서
상품코드
2052617
에피네프린 시장 : 제품 유형별, 용도별, 유통 채널별, 지역별Epinephrine Market, By Product Type, By Application, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
에피네프린 시장은 2026년에 36억 4,000만 달러에 달하고, 2033년까지 80억 5,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 12.0%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 36억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 12.00% | 시장 규모 예측(2033년) : | 80억 5,000만 달러 |
에피네프린(아드레날린이라고도 함)은 아나필락시스, 심정지, 표재성 출혈 등 다양한 증상의 치료에 사용되는 호르몬이자 의약품입니다. 주사제로서 혈관성 부종이나 아나필락시스 등의 알레르기 반응 치료에 사용됩니다. 또한, 운동 유발성 기관지 수축이 있는 사람이 천식 발작을 예방하기 위해 사용하는 경우도 있습니다. 천식 등의 질환 증가로 인해 에피네프린 자동 주사기에 대한 수요가 증가할 가능성이 있습니다. 아나필락시스 치료의 표준 요법으로 에피네프린이 자리 잡은 점과 자동 주사기의 기술적 발전이 시장 성장을 견인하는 요인이 될 것입니다.
시장 역학
세계 에피네프린 시장의 성장은 아나필락시스 및 알레르기 반응 발생률 증가, 투여 편의성을 높이는 자동 주사기의 기술적 발전, 응급 의료 현장에서 수요 증가, 그리고 아나필락시스 1차 치료제로서 에피네프린 자동 주사기의 채택 확대와 같은 요인들에 의해 주도되고 있습니다. 그러나 자동 주사기의 높은 비용, 주사용 에피네프린 공급 부족으로 인한 가격 급등, 그리고 대체 치료법에 대한 선호와 같은 요인들이 시장 성장을 저해할 가능성이 있습니다. 바이오시밀러 에피네프린의 등장과 개발도상국 시장 진출은 예측 기간 동안 시장 참여자들에게 성장 기회를 제공할 가능성이 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 에피네프린 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 에피네프린 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계 에피네프린 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 에피네프린 시장 : 제품 유형별(2021-2033년)
제5장 세계의 에피네프린 시장 : 용도별(2021-2033년)
제6장 세계의 에피네프린 시장 : 유통 채널별(2021-2033년)
제7장 세계의 에피네프린 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KTH 26.06.17Epinephrine Market is estimated to be valued at USD 3.64 Bn in 2026 and is expected to reach USD 8.05 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.64 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.00% | 2033 Value Projection: | USD 8.05 Bn |
Epinephrine, also known as adrenaline, is a hormone and medication that is used to treat a number of medical conditions such as anaphylaxis, cardiac arrest, and superficial bleeding. As an injection, it is used to treat allergic reactions like angioedema or anaphylaxis. It may also be used by people with exercise-induced bronchoconstriction to prevent asthma attacks. Rising diseases like asthma can boost demand for epinephrine auto-injectors. Emergence of epinephrine as the standard treatment for anaphylaxis along with technological advancements in autoinjectors can drive the market growth.
Market Dynamics
Global epinephrine market growth is driven by factors such as rising incidences of anaphylaxis and allergic reactions, technological advancements in auto-injectors improving ease of administration, increasing demand from emergency medical settings, and growing adoption of epinephrine auto-injectors as the first line treatment for anaphylaxis. However, factors such as high costs associated with auto-injectors, shortage of injectable epinephrine exacerbating prices, and preference for alternative therapeutic options can hamper the market growth. Emergence of biosimilar epinephrine and expansion into developing regions can offer growth opportunities for market players during the forecast period.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global epinephrine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, LLC, Kaleo, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global epinephrine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epinephrine market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2026 - 2033)
- Auto-injector
- Prefilled Syringes
- Ampoules and Vials
- Application Insights (Revenue, USD Bn, 2026 - 2033)
- Anaphylaxis
- Cardiac Arrest
- Superficial Bleeding
- Respiratory
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer
- Harvest Pharmaceuticals
- Grand Pharma
- Lincoln Medical, Ltd.
- Abbott Laboratories
- Sanofi S.A.
- Mylan, Inc.
- ALK Abello A/S
- Amedra Pharmaceuticals LLC
- Impax
- Emerade
- Tianjin Jinyao Group
- Sandoz Inc.
- Bausch Health Companies Inc.
- Antares Pharma Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Epinephrine Market, By Product Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Auto-injector
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Prefilled Syringes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ampoules and Vials
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Epinephrine Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Anaphylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cardiac Arrest
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Superficial Bleeding
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Respiratory Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Epinephrine Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Epinephrine Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Pfizer
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Harvest Pharmaceuticals
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Grand Pharma
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lincoln Medical, Ltd.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ALK Abello A/S
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amedra Pharmaceuticals LLC
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Impax
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Emerade
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Tianjin Jinyao Group
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sandoz Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Antares Pharma Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
